These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4048810)

  • 41. Bioavailability study on a new slow-release formulation of ketoprofen.
    Caruso I; Frigerio E; Fumagalli M; Liverta C; Moro L; Tamassia V
    J Int Med Res; 1982; 10(4):229-33. PubMed ID: 7117681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pharmacokinetic profil of ketoprofen (author's transl)].
    Caillé G; Besner JG; Brodeur J; Vezina M
    Ann Pharm Fr; 1978; 36(5-6):243-52. PubMed ID: 707953
    [No Abstract]   [Full Text] [Related]  

  • 43. Single and multiple dose pharmacokinetics of enteric coated ketoprofen: effect of cimetidine.
    Verbeeck RK; Corman CL; Wallace SM; Herman RJ; Ross SG; Le Morvan P
    Eur J Clin Pharmacol; 1988; 35(5):521-7. PubMed ID: 3234462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative pharmacokinetics of ketoprofen derived from single oral doses of ketoprofen capsules or a novel sustained-release pellet formulation.
    Houghton GW; Dennis MJ; Rigler ED; Parsons RL
    Biopharm Drug Dispos; 1984; 5(3):203-9. PubMed ID: 6487749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic characteristics of ketoprofen suppositories.
    Caillé G; Besner JG; Lacasse Y; Vézina M
    Biopharm Drug Dispos; 1980; 1(4):195-201. PubMed ID: 7448348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assay.
    Upton RA; Williams RL; Guentert TW; Buskin JN; Riegelman S
    Eur J Clin Pharmacol; 1981; 20(2):127-33. PubMed ID: 7262174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cellular uptake and subcellular distribution of two non-steroidal anti-inflammatory drugs: indomethacin and ketoprofen.
    Blanchard JC; Schneider YJ; Tulkens P; Trouet A
    Arch Int Pharmacodyn Ther; 1979 Jul; 240(1):4-16. PubMed ID: 507996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urinary pharmacokinetics of orally administered ketoprofen in man.
    Houghton GW; Dennis MJ; Rigler ED; Parsons RL
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):201-4. PubMed ID: 6519121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Differences in the effectiveness of ketoprofen administered per os and per rectum].
    Pavelka K; Vojtísek O; Bremová A
    Fysiatr Revmatol Vestn; 1979 Jul; 57(4):220-6. PubMed ID: 387563
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacokinetics of two rectal dosage forms of ketoprofen in patients after anal surgery.
    Kanamoto I; Nakagawa T; Horikoshi I; Koizumi T; Tazawa K; Fujimaki M
    J Pharmacobiodyn; 1988 Mar; 11(3):141-5. PubMed ID: 3411432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diffusion of intramuscular ketoprofen into the cerebrospinal fluid.
    Netter P; Lapicque F; Bannwarth B; Tamisier JN; Thomas P; Royer RJ
    Eur J Clin Pharmacol; 1985; 29(3):319-21. PubMed ID: 4076328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ketoprofen pharmacokinetics in the elderly: influence of rheumatic disease, renal function, and dose.
    Skeith KJ; Russell AS; Jamali F
    J Clin Pharmacol; 1993 Nov; 33(11):1052-9. PubMed ID: 8300888
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ketoprofen-aspirin interactions.
    Williams RL; Upton RA; Buskin JN; Jones RM
    Clin Pharmacol Ther; 1981 Aug; 30(2):226-31. PubMed ID: 7249506
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blood level studies on ketoprofen.
    Grahame R; Billings R; Reeback J; Gibson T; Burry HC; Gordon BH; Houghton GW; Lewellen OR; Templeton R
    Rheumatol Rehabil; 1978; Suppl():64-70. PubMed ID: 364614
    [No Abstract]   [Full Text] [Related]  

  • 55. [Pharmacologic and pharmacokinetic activity of ketoprofen lysine salt for topical administration].
    Borsa M; Malandrino S; Ronchi C; Tonon GC; Zanolo G
    Farmaco Prat; 1983 Feb; 38(2):87-96. PubMed ID: 6403380
    [No Abstract]   [Full Text] [Related]  

  • 56. [Analgesic efficacy of ketoprofen in continuous perfusion in refractory pain caused by bone metastases].
    Thyss A; Viens P; Caldani C; Schneider M
    Presse Med; 1987 Apr; 16(13):638. PubMed ID: 2952987
    [No Abstract]   [Full Text] [Related]  

  • 57. Reduced elimination of ketoprofen in the elderly is not necessarily due to impaired glucuronidation.
    Verbeeck RK; Wallace SM; Loewen GR
    Br J Clin Pharmacol; 1984 Jun; 17(6):783-4. PubMed ID: 6743473
    [No Abstract]   [Full Text] [Related]  

  • 58. Circadian phase-dependent pharmacokinetics and acute toxicity of mepivacaine.
    Bruguerolle B; Prat M
    J Pharm Pharmacol; 1988 Aug; 40(8):592-4. PubMed ID: 2907021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modelling circadian variation in the pharmacokinetics of non-steroidal anti-inflammatory drugs.
    Aronson JK; Chappell MJ; Godfrey KR; Yew MK
    Eur J Clin Pharmacol; 1993; 45(4):357-61. PubMed ID: 8299670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determination of the enantiomers of ketoprofen in blood plasma by ion-pair extraction and high-performance liquid chromatography of leucinamide derivatives.
    Björkman S
    J Chromatogr; 1987 Mar; 414(2):465-71. PubMed ID: 3571414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.